Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Precigen, Inc.
  6. Summary
    PGEN   US74017N1054

PRECIGEN, INC.

(PGEN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
5.89(c) 5.49(c) 5.47(c) 5.45(c) 5.48(c) Last
1 220 564 1 144 733 951 764 974 783 3 170 142 Volume
-4.69% -6.79% -0.36% -0.37% +0.55% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 107 M - -
Net income 2021 -99,3 M - -
Net Debt 2021 34,3 M - -
P/E ratio 2021 -11,2x
Yield 2021 -
Sales 2022 127 M - -
Net income 2022 -106 M - -
Net Debt 2022 71,2 M - -
P/E ratio 2022 -10,8x
Yield 2022 -
Capitalization 1 132 M 1 132 M -
EV / Sales 2021 10,9x
EV / Sales 2022 9,46x
Nbr of Employees 450
Free-Float 88,0%
More Financials
Company
Precigen, Inc., formerly Intrexon Corporation, forms collaborations to create biologically-based products and processes using synthetic biology. The Company's domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist... 
Sector
Biotechnology & Medical Research
Calendar
10/01 | 06:00amPresentation
More about the company
Ratings of Precigen, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about PRECIGEN, INC.
09/01PRECIGEN : to Present at the 2021 Wells Fargo Virtual Healthcare Conference and ..
PR
08/17INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Precigen
MT
08/13INSIDER TRENDS : Selling By Insiders Lingers at Precigen
MT
08/11INSIDER TRENDS : Insider Adds to Selling Trend at Precigen
MT
08/09INSIDER TRENDS : Selling By Insiders Lingers at Precigen
MT
08/09PRECIGEN : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/09PRECIGEN, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
08/09PRECIGEN : Earnings Flash (PGEN) PRECIGEN Reports Q2 Revenue $33.6M, vs. Street ..
MT
08/09Precigen, Inc. Reports Earnings Results for the Second Quarter Ended June 30,..
CI
08/05INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Precigen
MT
08/02INSIDER TRENDS : Insider Sales Add to 90-Day Trend at Precigen
MT
08/02PRECIGEN : to Announce Second Quarter and First Half 2021 Financial Results on A..
PR
06/30INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Precigen
MT
06/28INSIDER TRENDS : Precigen Insider Extends 90-Day Selling Trend
MT
06/15INSIDER TRENDS : Insider Adds to Selling Trend at Precigen
MT
More news
News in other languages on PRECIGEN, INC.

- No features available -

More news
Analyst Recommendations on PRECIGEN, INC.
More recommendations
Chart PRECIGEN, INC.
Duration : Period :
Precigen, Inc. Technical Analysis Chart | PGEN | US74017N1054 | MarketScreener
Technical analysis trends PRECIGEN, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 5,48 $
Average target price 12,50 $
Spread / Average Target 128%
EPS Revisions
Managers and Directors
Helen Sabzevari President, Chief Executive Officer & Director
Randal J. Kirk Executive Chairman
Thomas David Reed Chief Science Officer
Douglas E. Brough Head-Research
Rutul R. Shah Head-Operations & Portfolio
Sector and Competitors
1st jan.Capi. (M$)
PRECIGEN, INC.-46.27%1 132
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420